Related news from  |
Sat, 01 Aug 2026 14:09:11 +0000 |
Hercules Capital (HTGC) Q2 Beat Brings Its Valuation Narrative Back Into Focus
Why Hercules Capital’s latest quarter matters for shareholders Hercules Capital (HTGC) just reported Q2 2026 results that featured record originations, investment income and net investment income, alongside higher revenue and net income and early loan repayments that ran ahead of guidance. Management also highlighted steady portfolio credit quality, strong liquidity and ongoing contributions from the company’s private credit business. Taken together, these factors framed Q2 as an important...
|
Fri, 31 Jul 2026 13:53:00 +0000 |
HTGC Q2 Earnings Meet Estimates, Stock Up on Record Investment Income
Hercules Capital's shares up 3% after Q2 earnings meet estimates and record total investment income climbs 8.5%, while higher expenses weigh on performance.
|
Fri, 31 Jul 2026 11:04:07 +0000 |
Hercules Capital Q2 Earnings Call Highlights
Hercules Capital (NYSE:HTGC) reported record second-quarter investment income and net investment income, supported by strong originations, elevated early loan repayments and stable portfolio credit performance. Chief Executive Officer and Chief Investment Officer Scott Bluestein said the business c
|
Fri, 31 Jul 2026 05:01:57 +0000 |
Hercules Capital Inc (HTGC) (Q2 2026) Earnings Call Highlights: Record Income and Strategic ...
Hercules Capital Inc (HTGC) posts record Q2 2026 investment income and NAV growth, navigating competitive pressures with disciplined underwriting and robust portfolio health.
|
Fri, 31 Jul 2026 02:47:31 +0000 |
Hercules Capital (HTGC) Q2 2026 Earnings Call Transcript
Record originations of $2.74 billion drove net investment income to $92.9 million.
|
Thu, 30 Jul 2026 23:30:05 +0000 |
Hercules Capital (HTGC) Q2 Earnings Meet Estimates
Hercules Capital (HTGC) delivered earnings and revenue surprises of 0.00% and +0.14%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
|
Thu, 30 Jul 2026 20:05:00 +0000 |
Hercules Capital Reports Second Quarter 2026 Financial Results
SAN MATEO, Calif., July 30, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced its financial results for the second quarter ended June 30, 2026. The earnings release can be accessed at Hercules’ Investor Relations website at https://i
|
Wed, 29 Jul 2026 12:29:02 +0000 |
Hercules Capital Earnings: What To Look For From HTGC
Specialty finance company Hercules Capital (NYSE:HTGC) will be announcing earnings results this Thursday after market close. Here’s what to look for.
|
Tue, 28 Jul 2026 10:00:00 +0000 |
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Second Quarter 2026
SAN MATEO, Calif., July 28, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a second quarter 2026 total cash distribution of $0.47 per share. The following shows the key dates of the
|
Fri, 24 Jul 2026 20:05:00 +0000 |
Hercules Capital Closes Institutional Notes Offering of $325.0 Million 6.300% Unsecured Notes due 2031
SAN MATEO, Calif., July 24, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), today announced that it has closed an underwritten public offering of $325.0 million in aggregate principal amount of 6.300% notes due July 2031 (the "Notes").
|
Wed, 22 Jul 2026 22:15:02 +0000 |
Hercules Capital (HTGC) Falls More Steeply Than Broader Market: What Investors Need to Know
In the latest trading session, Hercules Capital (HTGC) closed at $15.93, marking a -1.24% move from the previous day.
|
Tue, 21 Jul 2026 20:15:00 +0000 |
Hercules Capital Prices Institutional Notes Offering of $325.0 Million 6.300% Notes due 2031
SAN MATEO, Calif., July 21, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), today announced that it has priced an underwritten public offering of $325.0 million in aggregate principal amount of 6.300% notes due July 2031 (the "Notes"). The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered and paid for on July 24, 2026.
|
Thu, 16 Jul 2026 22:15:02 +0000 |
Hercules Capital (HTGC) Advances While Market Declines: Some Information for Investors
The latest trading day saw Hercules Capital (HTGC) settling at $16.37, representing a +1.61% change from its previous close.
|
Thu, 16 Jul 2026 10:00:00 +0000 |
Hercules Capital Announces Date for Release of Second Quarter 2026 Financial Results and Conference Call
SAN MATEO, Calif., July 16, 2026--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2026 financial results conference call for Thursday, July 30, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will
|
Wed, 15 Jul 2026 14:01:50 +0000 |
Dyne Therapeutics (DYN) Inspires Confidence With Its Force Platform
Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the 10 affordable biotech stocks to buy right now. On June 26, TD Cowen initiated its coverage of Dyne Therapeutics Inc. (NASDAQ:DYN), assigning a Buy rating to the stock. The firm stated that the company’s Force platform has the potential to improve drug delivery in neuromuscular and CNS diseases […]
|
Wed, 15 Jul 2026 13:32:00 +0000 |
PhenixFIN (PFX) Soars 7.4%: Is Further Upside Left in the Stock?
PhenixFIN (PFX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
|
Thu, 09 Jul 2026 22:15:04 +0000 |
Hercules Capital (HTGC) Stock Dips While Market Gains: Key Facts
Hercules Capital (HTGC) reached $15.69 at the closing of the latest trading day, reflecting a -1.26% change compared to its last close.
|
Tue, 07 Jul 2026 21:15:01 +0000 |
Saratoga Investment (SAR) Q1 Earnings and Revenues Miss Estimates
Saratoga Investment (SAR) delivered earnings and revenue surprises of -12.96% and -2.82%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?
|
Sat, 04 Jul 2026 18:09:17 +0000 |
How Investors May Respond To Hercules Capital (HTGC) ESOP Equity Shelf And Potential Dilution Risk
In late June 2026, Hercules Capital, Inc. filed a shelf registration to offer 14,000,000 shares of common stock, totaling US$213.36 million, for an ESOP-related offering. This move adds a potential new source of equity capital at a time when the company’s earnings per share have been weakening and leverage is elevated. Now we’ll examine how this new equity shelf, and the risk of dilution it implies, could reshape Hercules Capital’s investment narrative. The future of work is here. Discover...
|
Sat, 04 Jul 2026 13:41:09 +0000 |
Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?
Targeted therapies meet AI-driven discovery as these biotech innovators reveal sharply contrasting financials, risk factors, and industry partnerships.
|